Health ❯ Healthcare

Biotechnology

Drug Development Gene Therapy Clinical Trials Cancer Treatment Gene Editing Pharmaceuticals Therapeutics Vaccines Sarepta Therapeutics Vaccine Development

UK and Singapore Unveil MHRA–HSA Innovation Corridor to Speed Patient Access to New Health Technologies

The corridor creates one early engagement route with both regulators for coordinated scientific advice.

MoonLake Faces Expanding Securities Suits as Lead-Plaintiff Deadline Nears

Skye Bioscience Investors Pressed to Seek Lead Role After Class Action Filing

Capricor’s HOPE-3 Trial Reports Cardiac and Muscle Gains in Duchenne Muscular Dystrophy

Novo Defends Semaglutide Alzheimer’s Strategy After Phase 3 Miss

Regeneron, Tessera Strike $150 Million Gene-Editing Pact for Alpha‑1 Antitrypsin Deficiency

Junshi’s Subcutaneous Toripalimab Matches IV in Phase 3 NSCLC Trial as Company Prepares NDA

Enlivex Raises $212 Million to Build RAIN Token Treasury, Plans Matteo Renzi Board Appointment

Moderna Secures $1.5 Billion Loan, Outlines Path to 2028 Breakeven

Protara Reports Strong Interim Phase 2 Results for TARA-002 in Pediatric Lymphatic Malformations

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

Casgevy Launch Stumbles, Yet Analysts Eye Upside for CRISPR Therapeutics

Zymeworks Shifts to Royalty Model After Ziihera’s Phase 3 Win in HER2‑Positive Gastroesophageal Cancer

FDA Adds Boxed Liver Warning and Limits Elevidys to Ambulatory Boys 4 and Up

Sofinnova Closes €650 Million Capital XI to Back Early-Stage Biotech and Medtech

Mid-Cap Fund Letters Credit Fed Cuts for Q3 Rally, Detail Stock-Driven Gains and Moves

Propanc Biopharma Lines Up Up to $100 Million From Hexstone to Launch Digital-Asset Treasury and Speed PRP Toward Trials

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

MoonLake Investors Courted for Lead Role in SDNY Securities Case After SLK Trial Collapse

Braveheart Bio Launches With $185 Million Series A to Advance HCM Drug